about
Impact of surgical volume of centers on post-operative outcomes from cytoreductive surgery and hyperthermic intra-peritoneal chemoperfusionA literature review of radiological findings to guide the diagnosis of gallbladder adenomyomatosis.Hyperthermic Intraperitoneal Chemotherapy and Cytoreductive Surgery in the Management of Peritoneal CarcinomatosisRole of laparoscopy in patients with peritoneal metastases considered for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC).Surgical management of hepatic hemangiomas: a multi-institutional experienceSuicide in patients with pancreatic cancer.Is local resection adequate for T1 stage ampullary cancer?Diagnostic laparoscopy should be performed before definitive resection for pancreatic cancer: a financial argumentThe use of isolated limb infusion in limb threatening extremity sarcomasSurgical resection versus ablation for hepatocellular carcinoma ≤ 3 cm: a population-based analysis.Comparative Effectiveness of Hepatic Artery Based Therapies for Unresectable Colorectal Liver Metastases: A Meta-Analysis.Tumor profiling of gastric and esophageal carcinoma reveal different treatment optionsAn elevated body mass index does not reduce survival after esophagectomy for cancerIntrahepatic cholangiocarcinoma and gallbladder cancer: distinguishing molecular profiles to guide potential therapy.Cost and Morbidity Analysis of Chest Port Insertion: Interventional Radiology Suite Versus Operating RoomRecurrence after microwave ablation of liver malignancies: a single institution experience.Viral status at the time of liver transplantation for hepatocellular carcinoma: a modern predictor of longterm survivalStaging chest computed tomography and positron emission tomography in patients with pancreatic adenocarcinoma: utility or futility?The surgical treatment of breast cancer in the elderly: a single institution comparative review of 5235 patients with 1028 patients ≥70 years.The Frey procedure for chronic pancreatitis secondary to pancreas divisum.Ciliated hepatic cyst leading to squamous cell carcinoma of the liver - A case report and review of the literatureReview of the impact of antineoplastic therapies on the risk for cholelithiasis and acute cholecystitis.Management of acute cholecystitis in cancer patients: a comparative effectiveness approach.Systematic review of outcomes of patients undergoing resection for colorectal liver metastases in the setting of extra hepatic disease.The American Society of Peritoneal Surface Malignancies (ASPSM) Multiinstitution Evaluation of the Peritoneal Surface Disease Severity Score (PSDSS) in 1,013 Patients with Colorectal Cancer with Peritoneal Carcinomatosis.Surgical management of bowel obstruction in patients with peritoneal carcinomatosis.Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: a systematic review and meta-analysis.Comparative effectiveness of hepatic artery based therapies for unresectable intrahepatic cholangiocarcinoma.Incorporation of diagnostic laparoscopy in the management algorithm for patients with peritoneal metastases: A multi-institutional analysis.Neoadjuvant radiotherapy for retroperitoneal sarcoma: A systematic review.Factors associated with palliative care use in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.Hepatic Perfusion Therapy.Morbidity of Curative Cancer Surgery and Suicide Risk.Management of Malignant Peritoneal Mesothelioma Using Cytoreductive Surgery and Perioperative Chemotherapy.Palliative interventions for hepatocellular carcinoma patients: analysis of the National Cancer Database.Neutrophil-to-lymphocyte ratio as a predictor of outcomes for patients with hepatocellular carcinoma: a Western perspective.Current management strategies for peritoneal mesothelioma.Ablation for hepatocellular carcinoma: validating the 3-cm breakpoint.Single-stage resection and microwave ablation for bilobar colorectal liver metastases.Conditional Survival as a Patient Centered Metric for Patients with Appendiceal Adenocarcinoma.
P50
Q26768302-E6244196-5A27-448C-97B9-FE3A61674716Q26768399-7FEFABDC-2532-487D-8191-81376EF40BC3Q28077394-B058185C-1A76-4CC0-89A3-06189B12722DQ34130132-28B444FD-7696-4136-A189-CA6EAD4F43F1Q34548925-729BFB66-3677-434F-8BD6-DEAE83085C15Q34623223-980E2950-58C4-4B0F-B450-0FA0A7807645Q34702105-902F97F5-BB86-4F92-BC91-DF898F04AE35Q34986176-BD48676C-5025-4D73-87EB-130D83F04C5AQ35871652-1392ED45-30BF-4575-BCE6-AEA51E1252C2Q36064758-84EB08CE-0578-452E-B1A9-2CA32571A367Q36137048-1BAA62F1-0054-4CC4-BB39-E571E4ABA12EQ36214575-9BE1BAB1-1479-4670-98AA-97B26C597E37Q36216601-DB1A0181-E0E0-4BE5-BFC1-1A9D8FD233AFQ36278688-6C4641A7-9397-4C01-AD70-8F55D85DAE56Q36306994-DDED640B-77A6-471A-9F56-00F915ADE597Q36786156-94D0E2EF-14EE-4DF1-80A7-8232089969E1Q37216659-351EC4F8-8916-43C4-881E-FCE72749852EQ37480860-11103819-82C6-4026-8070-8D8713D371F9Q38041586-758CEEF8-F0CA-467E-BE42-BA032F23AB7BQ38134272-EECA7DB7-01AA-483B-B17D-C54EA37A7E97Q38140517-4EE7A576-394D-42C4-B5F9-34B9BB7D2DD4Q38151492-3B799FF4-CF80-4942-8F28-3E33B1627211Q38200940-78E776AD-3D38-4E76-A44D-2793C820C5B7Q38207240-C3BE181D-4853-4785-8707-F85D2C181C5BQ38214032-1DD779E0-6B72-4D76-90C3-00431F155715Q38225442-968593E6-B7DD-4F58-90C7-65609834E8C8Q38240009-5633F731-AFDB-45BF-A092-8217F242711BQ38245162-D665AE2B-0B11-45D8-BF50-A030BA0E2D3DQ38514813-493E9DD6-5550-417C-B4D0-BBB36CDE479BQ38779916-0549E831-F830-4115-9562-386F340B5868Q38788001-6CC7F3D7-FBDA-4B33-829B-08A74800D935Q38790337-32C77619-32CA-4BBC-895C-A04D882EA995Q38898200-0FF5B507-D122-4155-87C2-B8188479AAAAQ39011977-4C185871-2759-4857-97C6-363A0F2F54D7Q39161581-D4200B13-D33D-41E7-9605-F0761369156AQ39333416-2BD476E9-9CEB-423A-A977-72F3A1789019Q39406611-29C49EDA-F450-4990-94E2-73857566B193Q39410834-A2D4166A-709E-4F21-9062-75D4B71995A6Q39757307-7AC9F91E-59CD-4F48-B67E-4E2049F8F7FAQ40013737-2E0944F1-16B7-4253-A009-454EBBA280D7
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Kiran K Turaga
@en
Kiran K Turaga
@nl
type
label
Kiran K Turaga
@en
Kiran K Turaga
@nl
prefLabel
Kiran K Turaga
@en
Kiran K Turaga
@nl
P31
P496
0000-0001-8541-586X